Acorda Therapeutics Price History

ACORDelisted Stock  USD 16.20  0.40  2.41%   
If you're considering investing in Acorda Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acorda Therapeutics stands at 16.20, as last reported on the 16th of December 2024, with the highest price reaching 16.60 and the lowest price hitting 15.17 during the day. We have found twenty-nine technical indicators for Acorda Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Acorda Therapeutics' Risk Adjusted Performance of 0.0796, downside deviation of 5.94, and Mean Deviation of 5.6 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Acorda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ACOR
Based on monthly moving average Acorda Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acorda Therapeutics by adding Acorda Therapeutics to a well-diversified portfolio.

Acorda Therapeutics Stock Price History Chart

There are several ways to analyze Acorda Stock price data. The simplest method is using a basic Acorda candlestick price chart, which shows Acorda Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Acorda Stock Price History Data

The price series of Acorda Therapeutics for the period between Tue, Sep 17, 2024 and Mon, Dec 16, 2024 has a statistical range of 8.6 with a coefficient of variation of 19.89. The prices are distributed with arithmetic mean of 12.79. The median price for the last 90 days is 12.59. The company had 1:20 stock split on 5th of June 2023. Acorda Therapeutics issued dividends on 2021-01-04.
OpenHighLowCloseVolume
12/16/2024
 16.60  16.60  15.17  16.20 
07/24/2023 16.60  16.60  15.17  16.20  13,601 
07/21/2023 16.24  16.79  16.24  16.77  5,800 
07/20/2023 16.04  16.95  16.02  16.45  11,445 
07/19/2023 16.31  16.55  16.00  16.35  7,906 
07/18/2023 16.80  16.80  16.02  16.43  6,901 
07/17/2023 15.18  16.95  14.81  16.65  12,929 
07/14/2023 15.54  15.54  15.11  15.48  4,016 
07/13/2023 15.15  15.65  15.15  15.60  11,328 
07/12/2023 14.44  15.30  14.44  15.15  10,256 
07/11/2023 13.32  14.99  13.32  14.44  17,304 
07/10/2023 13.26  13.98  12.80  13.98  11,756 
07/07/2023 13.46  13.69  13.14  13.40  2,434 
07/06/2023 12.80  13.64  12.80  13.26  6,311 
07/05/2023 12.69  13.46  12.68  13.00  4,945 
07/03/2023 13.07  13.07  12.42  12.45  3,829 
06/30/2023 12.54  13.50  12.54  13.01  8,033 
06/29/2023 12.62  12.98  12.62  12.81  3,542 
06/28/2023 11.84  12.82  11.81  12.59  11,738 
06/27/2023 12.57  13.10  11.62  11.91  5,392 
06/26/2023 11.82  13.15  11.82  12.57  7,306 
06/23/2023 12.60  13.19  12.52  12.58  2,776 
06/22/2023 12.75  13.55  12.35  12.99  14,479 
06/21/2023 12.43  13.65  12.32  12.81  36,499 
06/20/2023 12.75  12.81  12.56  12.56  10,418 
06/16/2023 11.40  13.20  11.11  12.91  41,544 
06/15/2023 11.37  12.33  10.55  11.90  47,671 
06/14/2023 10.51  14.18  10.06  12.10  362,278 
06/13/2023 9.87  10.48  9.80  10.33  8,875 
06/12/2023 10.03  10.42  9.61  10.08  22,500 
06/09/2023 10.62  10.76  10.01  10.03  14,753 
06/08/2023 11.40  11.70  10.33  10.84  52,657 
06/07/2023 9.75  12.43  9.75  11.64  127,726 
06/06/2023 9.93  10.55  9.75  10.21  20,701 
06/05/2023 9.22  10.29  9.20  10.22  28,086 
06/02/2023 11.00  12.00  10.00  10.00  17,195 
06/01/2023 0.52  11.08  11.08  11.08  19,532 
05/31/2023 12.20  12.80  11.91  12.00  4,391 
05/30/2023 11.96  13.00  11.96  12.24  8,082 
05/26/2023 0.65  11.89  11.89  11.89  9,203 
05/25/2023 0.64  13.00  13.00  13.00  14,222 
05/24/2023 0.67  12.90  12.90  12.90  10,350 
05/23/2023 0.74  13.80  13.80  13.80  11,368 
05/22/2023 0.77  14.49  14.49  14.49  11,927 
05/19/2023 0.77  15.39  15.39  15.39  3,022 
05/18/2023 0.77  15.60  15.60  15.60  15,312 
05/17/2023 0.79  16.20  16.20  16.20  25,358 
05/16/2023 0.63  16.00  16.00  16.00  26,690 
05/15/2023 0.68  12.57  12.57  12.57  17,871 
05/12/2023 0.84  13.90  13.90  13.90  53,727 
05/11/2023 0.80  16.80  16.80  16.80  27,620 
05/10/2023 0.86  17.02  17.02  17.02  70,445 
05/09/2023 0.78  17.60  17.60  17.60  168,703 
05/08/2023 0.56  17.60  17.60  17.60  2,039,376 
05/05/2023 0.49  9.90  9.90  9.90  1,093 
05/04/2023 0.50  9.40  9.40  9.40  2,068 
05/03/2023 0.50  9.80  9.80  9.80  2,798 
05/02/2023 0.48  9.40  9.40  9.40  1,077 
05/01/2023 0.45  9.48  9.48  9.48  923.00 
04/28/2023 0.49  9.30  9.30  9.30  1,824 
04/27/2023 0.46  9.44  9.44  9.44  1,421 

About Acorda Therapeutics Stock history

Acorda Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acorda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acorda Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acorda Therapeutics stock prices may prove useful in developing a viable investing in Acorda Therapeutics
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York. Acorda Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.

Acorda Therapeutics Stock Technical Analysis

Acorda Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Acorda Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Acorda Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Bonds Directory Now

   

Bonds Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Acorda Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Acorda Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Acorda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acorda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Consideration for investing in Acorda Stock

If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets